The company's key product is the Senza spinal cord stimulation system, which generates electrical impulses to relieve pain and is implanted by physicians and controlled by patients. The system includes leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States, but also receives revenue from Australia, the United Kingdom, and Germany. The company's HFX solution offers a comprehensive approach to pain relief, including the Senza system and support services for the treatment of chronic pain, including painful diabetic neuropathy when programmed with a frequency of 10 kHz.